Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
Cy3 TSA Fluorescence System Kit for Astrocyte Mapping
2026-08-11
Translate astrocyte atlas discoveries into spatially resolved protein, RNA, and morphology assays with a sensitive Cy3 TSA workflow. This TSA fluorescence kit is especially useful when conventional fluorescence microscopy detection cannot reliably reveal low-abundance targets in fixed brain tissue or cells.
Br-DAPI in Diabetic Cardiomyopathy DNA Assays
2026-08-11
Br-DAPI is a DAPI fluorescent dye for selective DNA labeling in live and fixed cells. This article explains how its staining chemistry can strengthen diabetic cardiomyopathy assays while clarifying what DNA fluorescence can—and cannot—prove about lipotoxicity, ER stress, and apoptosis.
Anti Reverse Cap Analog for mRNA Workflows
2026-08-10
Learn how Anti Reverse Cap Analog (ARCA) improves orientation-controlled synthetic mRNA capping for reporter assays, LNP delivery, gene editing, and reprogramming research. A practical workflow connects cap chemistry with the targeted mRNA nanoparticle strategy reported in ACS Nano while separating demonstrated findings from optimization hypotheses.
Tubastatin A in Porcine Post-Resuscitation Injury
2026-08-09
A porcine cardiac arrest study found that Tubastatin A reduced post-resuscitation myocardial dysfunction, cardiac injury biomarkers, and tissue signals associated with GSDME-mediated pyroptosis and MLKL-mediated necroptosis. The work supports a mechanistic link between HDAC6 inhibition and myocardial ischemia–reperfusion protection, while its small, short-term design limits clinical and causal interpretation.
Ginkgo Cocktail Enhances Yeast Mitochondrial Longevity
2026-08-08
The reference study combines LC-MS/MS profiling, network pharmacology, and yeast aging assays to identify a four-compound Ginkgo biloba cocktail that improves mitochondrial function and extends chronological lifespan. Its main practical contribution is a data-guided strategy for testing combinations of natural products rather than assuming that activity from a crude extract is attributable to one dominant molecule.
X-Gal as a Decision Tool in Molecular Cloning
2026-08-07
X-Gal turns β-galactosidase activity into a visible molecular cloning decision, but its greatest value depends on interpreting color as evidence rather than proof. This article connects blue-white colony screening with activity-dependent biology and shows how to design more discriminating, reproducible assays.
Self-Assembling Virus-Mimicking Particles for Extrahepatic m
2026-08-07
This article examines a recent innovation in mRNA therapeutics: the self-assembling enveloped virus-mimicking particle (EVMP) platform. By enabling precise and efficient delivery of mRNA to extrahepatic tissues, this technology addresses longstanding challenges in mRNA-based immunotherapy and gene modulation, with notable implications for cytokine mRNA applications.
Vemurafenib (PLX4032): Applied Workflows for Melanoma Resear
2026-08-06
Vemurafenib (PLX4032) enables precise inhibition of BRAF V600E-driven pathways and robust modeling of resistance in melanoma research. This guide details experimental protocols, advanced troubleshooting, and strategic insights—bridging cutting-edge multi-omics findings to practical laboratory execution.
Polybrene (Hexadimethrine Bromide): Advancing Precision in G
2026-08-06
Explore the multifaceted roles of Polybrene (Hexadimethrine Bromide) in viral transduction, lipid-mediated DNA delivery, and proteomics. This article provides in-depth scientific analysis and practical protocols, setting it apart from standard product overviews.
Flumequine in DNA Topoisomerase II Modulation: Assay Design
2026-08-05
Explore Flumequine as a DNA topoisomerase II inhibitor through the lens of advanced assay design, integrating cutting-edge in vitro evaluation strategies. This article offers a unique, practical guide for researchers in DNA replication and cancer biology.
Cy3 TSA Fluorescence System Kit: Precision Signal Amplificat
2026-08-05
Explore how the Cy3 TSA Fluorescence System Kit empowers high-sensitivity detection of low-abundance biomolecules in cardiovascular pathology. This article uniquely integrates advanced tyramide signal amplification with new mechanistic insights on endothelial-driven cardiotoxicity, offering a fresh perspective for translational researchers.
DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe: Te
2026-08-04
DiI (DiIC18(3)) enables robust, selective plasma membrane labeling where aqueous or organelle-selective dyes are ineffective. It should not be used in water-based protocols or for exclusive organelle staining, as its performance depends on correct lipid membrane incorporation and solvent compatibility.
Atropo-Enantioselective Suzuki Coupling for Axially Chiral B
2026-08-04
This study pioneers the catalytic asymmetric synthesis of an axially chiral antimitotic biaryl via an atropo-enantioselective Suzuki cross-coupling. The approach enables access to structurally complex analogues of rhazinilam, offering new directions for anticancer research and chiral biaryl synthesis.
X-Gal in Molecular Cloning: Optimized Workflows and OSN Assa
2026-08-03
X-Gal (5-bromo-4-chloro-indolyl-β-D-galactopyranoside) is indispensable for blue-white colony screening and β-galactosidase activity assays, offering high sensitivity and reproducibility. This article explores advanced experimental workflows, troubleshooting strategies, and recent innovations that leverage APExBIO’s high-purity X-Gal for molecular cloning and olfactory sensory neuron research.
Targeting Pancreatic Fibrosis via MFGE8-ANXA1-SMAD2/3 Modula
2026-08-03
This study provides compelling evidence that umbilical cord-derived mesenchymal stem cells (UCMSCs) and their extracellular vesicles (EVs) can attenuate pancreatic fibrosis in chronic pancreatitis by modulating the MFGE8-dependent ANXA1-SMAD2/3 axis. The findings open new avenues for regenerative and nanomedicine-based interventions in pancreatic disease models.
8098 records 9/540 page Previous Next First page 上5页 678910 下5页 Last page